The event, which was due to take place from 16th – 18th March 2020, has been put on hold.
The decision to postpone the event was not one taken lightly and has been taken in agreement with all stakeholders involved. We are currently looking into alternative dates and venues for CPhI Japan 2020 and will keep you informed.
We will be in touch shortly to communicate revised show dates and location.
The 2020 Global Drug Bioavailability Enhancement Summit will provide a holistic overview to bioavailability enhancements. 2020’s Summit covers everything from large molecules to small molecules.
We are happy to invite you during the New York NY Summit, The New Yorker, A Wyndham Hotel (January 28-29, 2020).
Please, for more information check the website https://curtiscoulter.com/2020-global-drug-bioavailability-enhancement-summit/agenda/. See you there!
We will be pleased to welcome you at our exhibition booth during the 30th CPhI Worldwide in Frankfurt, Germany (5 – 7 November 2019).
MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased to welcome you at Booth 40B10.
Please, check our video invitation below and visit us at our Booth 40B10 !
MUNIT announces its participation at the 6th Controlled and Modified Drug Release Summit (August 27th – 29th 2019) in Philadelphia and the 9th American DDF Summit in Boston, September 9th – 10th 2019.
Our sales team would be delighted to welcome you at our booth.
We will be pleased to welcome you at our exhibition booth during the 5th Annual Formulation & Drug Delivery Congress in London (29 – 30 April 2019) and the Respiratory Drug Delivery Europe congress 2019 in Lisbon, Portugal, May 7-10, 2019.
Munit will participate the the this years
Formulation and Drug Delivery Summit in San Diego (USA)
DCAT New York (USA) and
CPhI Tokyo (Japan).
We are looking forward seeing you at one of this events!
MUNIT will participate at this year’s European DDF-Summit in Berlin, from March 11th to March 13th 2018. You are welcome to visit us at our booth!
MUnit is exhibiting at the forthcoming Drug Delivery to the Lungs (DDL) conference at Edinburgh International Conference Centre.
The event is Europe’s premier conference and industry exhibition dedicated to pulmonary and nasal drug delivery. It runs from 12-14 December 2018
MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased to welcome you at booth 165.
MUNIT has announced it will be participating at the 5th Annual Controlled & Modified Drug Release Summit in Philadelphia, US.
The event will take place from 28-29 November at the Marriot Philadelphia Downtown Hotel.
This industry-leading event will bring together key decision makers and innovators within the controlled and modified drug release market, where particle size reduction is a key step.
Find out more about this topic at MUNIT’s booth.
MUNIT announces its participation at the 6th Annual World HPAPI congress in Basel, Switzerland. The event will take place from October 29th to October 31st and is co-located with the European Antibody , World Biosimilar and World Immunotherapy Congress.
Pls. visit us at booth 33.